Open Insider Trading Activity for Turning Point Therapeutics, Inc. President & CEO Countouriotis Athena
31-day price and insider activity (up to 2 years)
Daily candles with triangles for the buy and sale transactions shown below. Scroll left or zoom out to load earlier candles (up to 2 years).
▲ Insider buy
▼ Insider sale
Loading daily price history…
Charting by TradingView Lightweight Charts
| Ticker | Filing Date | Transaction Date | Company | Insider | Title | Transaction | Trade Count | Shares | Avg. Price | Total Value | Position Size Change | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting TPTX | 2022-02-11 | 2022-02-09 | Turning Point Therapeutics, Inc. | Countouriotis Athena | President & CEO | Sell | 1 | 2,971 | $36.30 | $107,847.30 | 5.84% | View Filing |
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. TPTX | 2020-05-26 | 2020-05-21 | Turning Point Therapeutics, Inc. | Countouriotis Athena | President & CEO | Buy | 1 | 4,166 | $60.00 | $249,960.00 | 15.50% | View Filing |